Data dictionary: Breast Cancer - NBCA: Difference between revisions
From Beacon
(Created page with "Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page. This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. '''Patient Information''' * Health Facility * Unique Patient Number * Date of Birth * Gender * Date of Death (if applicable) * Cause of Death '''Treatment Details''' * Episode Start Date (Incidence Date) * Ha...") |
No edit summary |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forresearchers</span> | |||
<span style="display:none">thenetherlandscountry</span> | |||
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page. | Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page. | ||
This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. | This is a summary of the variables available in the database. You can download the complete data dictionary. [https://dica.nl/data-aanvragen/ Click here to learn more]. | ||
''' | '''Table 1:''' Patient Information. | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Health Facility | |||
|- | |||
| Unique Patient Number | |||
|- | |||
| Date of Birth | |||
|- | |||
| Gender | |||
|- | |||
| Date of Death (if applicable) | |||
|- | |||
| Cause of Death | |||
|} | |||
'''Table 2:''' Treatment Details. | |||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Episode Start Date (Incidence Date) | |||
|- | |||
| Has the patient participated in a registered trial? | |||
|- | |||
| Has the patient received neo-adjuvant therapy (min. 4 weeks before surgery)? | |||
|- | |||
| Start Date of Neo-adjuvant Therapy | |||
|- | |||
| End Date of Neo-adjuvant Therapy | |||
|- | |||
| Number of Neo-adjuvant Cycles Actually Given | |||
|- | |||
| Neo-adjuvant Chemotherapy | |||
|- | |||
| Adjuvant Chemotherapy Actually Received by the Patient | |||
|- | |||
| Start Date of Adjuvant Chemotherapy | |||
|- | |||
| End Date of Adjuvant Chemotherapy | |||
|- | |||
| Number of Adjuvant Cycles Actually Given | |||
|- | |||
| Adjuvant Immunotherapy Received by the Patient | |||
|- | |||
| Complicated Course After Chemotherapy | |||
|} | |||
''' | '''Table 3:''' Diagnosis and Pathology. | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Lateralization of this Tumour | |||
|- | |||
| Is there a history? It concerns the history of (one of) the breast(s). | |||
|- | |||
| Was the tumour discovered during population screening (screening)? | |||
|- | |||
| Is the tumour palpable? | |||
|- | |||
| Final BIRADS classification after imaging (before biopsy) | |||
|- | |||
| Incidence Date (date of first tumour-positive biopsy based on cytology or histology) | |||
|- | |||
| Invasiveness | |||
|- | |||
| Histological Type | |||
|- | |||
| Estrogen Receptor % | |||
|- | |||
| Progesterone Receptor % | |||
|- | |||
| HER-2 Determination | |||
|} | |||
'''Table 4:''' Surgical and Oncological Treatment. | |||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Date of First Tumour Excision | |||
|- | |||
| Type of Breast Operation at First Tumour Excision | |||
|- | |||
| Was the Plastic Surgeon Involved in the Surgery? | |||
|- | |||
| Sentinel Lymph Node Biopsy Done? | |||
|- | |||
| Date of Sentinel Lymph Node Biopsy | |||
|- | |||
| Result of Sentinel Lymph Node Biopsy | |||
|- | |||
| Was there an Axillary Lymph Node Dissection? | |||
|- | |||
| Date of Axillary Lymph Node Dissection | |||
|} | |||
''' | '''Table 5:''' Radiation and Postoperative Details. | ||
{| class="wikitable" | |||
! Variables | |||
|- | |||
| Radiotherapy | |||
|- | |||
| Type of Radiotherapy Received by the Patient | |||
|- | |||
| Radiotherapy Institute Where the Radiotherapy Was Given | |||
|- | |||
| Start Date of Radiotherapy | |||
|- | |||
| End Date of Radiotherapy | |||
|- | |||
| Was the Patient Discussed in a Multidisciplinary Team Post-Operation? | |||
|} | |||
'''Table 1:''' COVID-19 Specific. | |||
''' | {| class="wikitable" | ||
! Variables | |||
|- | |||
| Was there a (clinical) suspicion or a test for SARS-CoV-2 infection in the period before admission to 30 days after admission? | |||
|- | |||
| Date of First Suspicion of SARS-CoV-2 Infection | |||
|- | |||
| Date of First Specific Test for SARS-CoV-2 Infection | |||
|- | |||
| Date of First Positive Lab Test for SARS-CoV-2 | |||
|- | |||
| ICU Admission Date and Time | |||
|- | |||
| ICU Discharge Date and Time | |||
|- | |||
| Discharge Destination after ICU Stay | |||
|- | |||
| Final Status Regarding SARS-CoV-2 | |||
|} | |||
Latest revision as of 17:42, 4 December 2025
Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.
This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.
Table 1: Patient Information.
| Variables |
|---|
| Health Facility |
| Unique Patient Number |
| Date of Birth |
| Gender |
| Date of Death (if applicable) |
| Cause of Death |
Table 2: Treatment Details.
| Variables |
|---|
| Episode Start Date (Incidence Date) |
| Has the patient participated in a registered trial? |
| Has the patient received neo-adjuvant therapy (min. 4 weeks before surgery)? |
| Start Date of Neo-adjuvant Therapy |
| End Date of Neo-adjuvant Therapy |
| Number of Neo-adjuvant Cycles Actually Given |
| Neo-adjuvant Chemotherapy |
| Adjuvant Chemotherapy Actually Received by the Patient |
| Start Date of Adjuvant Chemotherapy |
| End Date of Adjuvant Chemotherapy |
| Number of Adjuvant Cycles Actually Given |
| Adjuvant Immunotherapy Received by the Patient |
| Complicated Course After Chemotherapy |
Table 3: Diagnosis and Pathology.
| Variables |
|---|
| Lateralization of this Tumour |
| Is there a history? It concerns the history of (one of) the breast(s). |
| Was the tumour discovered during population screening (screening)? |
| Is the tumour palpable? |
| Final BIRADS classification after imaging (before biopsy) |
| Incidence Date (date of first tumour-positive biopsy based on cytology or histology) |
| Invasiveness |
| Histological Type |
| Estrogen Receptor % |
| Progesterone Receptor % |
| HER-2 Determination |
Table 4: Surgical and Oncological Treatment.
| Variables |
|---|
| Date of First Tumour Excision |
| Type of Breast Operation at First Tumour Excision |
| Was the Plastic Surgeon Involved in the Surgery? |
| Sentinel Lymph Node Biopsy Done? |
| Date of Sentinel Lymph Node Biopsy |
| Result of Sentinel Lymph Node Biopsy |
| Was there an Axillary Lymph Node Dissection? |
| Date of Axillary Lymph Node Dissection |
Table 5: Radiation and Postoperative Details.
| Variables |
|---|
| Radiotherapy |
| Type of Radiotherapy Received by the Patient |
| Radiotherapy Institute Where the Radiotherapy Was Given |
| Start Date of Radiotherapy |
| End Date of Radiotherapy |
| Was the Patient Discussed in a Multidisciplinary Team Post-Operation? |
Table 1: COVID-19 Specific.
| Variables |
|---|
| Was there a (clinical) suspicion or a test for SARS-CoV-2 infection in the period before admission to 30 days after admission? |
| Date of First Suspicion of SARS-CoV-2 Infection |
| Date of First Specific Test for SARS-CoV-2 Infection |
| Date of First Positive Lab Test for SARS-CoV-2 |
| ICU Admission Date and Time |
| ICU Discharge Date and Time |
| Discharge Destination after ICU Stay |
| Final Status Regarding SARS-CoV-2 |